Allocations
A subsidiary of Ares Management Corporation is to acquire 100 per cent of Black Creek Group’s US real estate investment advisory and distribution business (Black Creek).
Founded in 1993, Black Creek had approximately USD11.6 billion of assets under management, as of 31 March, 2021, in core/core-plus real estate strategies across two non-traded Real Estate Investment Trusts (REITs) and various institutional fund vehicles. Black Creek’s senior management team has an average of 25 years of experience in sourcing, acquiring, operating and developing properties in the US. Supported by large institutional investors and an established retail investor base, Black Creek has a
European private credit firm Kartesia has held a final close at the hardcap of EUR1.5 billion for the fifth vintage of its flagship Credit Opportunities fund, following the close of its predecessor in 2017 at EUR870 million.
Leif, a technology company dedicated to increasing access to quality and affordable education, has completed a strategic financing round totaling more than USD60 million. Leif intends to use the new financing to strategically expand its platform to meet the increasing demand for outcomes-aligned tuition financing solutions, which have had significant impact for students and schools.
The strategic financing includes:
LL Funds, LLC, an independent investment firm focused on specialty consumer finance investments, has committed a new USD50 million credit facility to Leif’s platform of existing capital partners and has committed to invest USD10 million in equity
Insita Group LTD, a
The Lakes Distillery, a whiskymaker with an artistic ethos, expects to see a 70 per cent growth in the production of its single malt whisky in the next 12 months following the reengagement of its capital expenditure (CapEx) project, assisted by ABL funding from Secure Trust Bank Commercial Finance.
When the pandemic hit in March 2020, The Lakes Distillery, was forced to close its hospitality offering and temporarily put a pause on its CapEx project which plans to treble production.
Despite these immediate changes, the distillery was able to continue its production of single malt whisky, due to the flexibility
CAPZA, an independent management company and leading player in private investments in European SMEs, has acquired a minority stake in LuxCarta, a specialist in the creation and delivery of digital maps to the global telecom, simulation & training and other vertical markets. CAPZA’s investment in LuxCarta will occur through its CAPZA Transition fund. Its goal is to support the growth strategy of the company set by LuxCarta’s founding directors and existing investor BNP Paribas Développement.
LuxCarta is the leading producer of high-resolution geospatial models derived from earth observation imagery to the telecom industry and supports more than 150 operators around the
White Star Capital, a global multi-stage technology venture capital investment platform, has held the final closing of its USD50 million Digital Asset Fund (DAF), a specialised fund investing in crypto-networks and blockchain-enabled businesses at each layer of the tech stack.
The fund exceeded its previously announced target by USD20 million and is backed by major institutional investors and corporations, including Bpifrance and Ubisoft.
“It’s critical that emerging crypto and blockchain-enabled start-ups receive investment from firms and professionals who have the experience and knowledge to help drive their businesses forward,” says Yoann Caujolle, Managing Director of Bpifrance. “We’re pleased to partner
Vly, provider of a pea-based milk alternative, has secured an investment of EUR6.1 million from FoodTech investors Five Seasons Ventures, alongside previous investors Global Founders Capital and Good Seed Ventures.
The investment will be used to scale in DACH and new European markets, including the UK, further product development and key talent.
Vly was founded in 2018 by Niklas Katter, Moritz Braunwarth and Nicolas Hartmann, who saw an opportunity for a healthy milk alternative that was high in protein, low sugar, and didn’t use any ingredients associated with common allergies, such as nuts or oats. Valuing health and innovation from
SFW Capital Partners (SFW) has completed a majority recapitalisation of Pion Inc, a provider of analytical instrumentation for formulation development and quality control in the life sciences industry.
Mike and Sharon Kelly, who have owned and operated Pion for the last decade, are reinvesting in the transaction to retain an interest in the company.
Founded in 1996, Pion is best known for providing instrumentation, software, reagents, and services to enable pharmaceutical scientists to develop medications that are safe and effective. Pion’s unique fibre-optic and PhysChem analysis technology play a critical role in the screening, development, production and quality
Pemberton, a leading European private debt manager transforming traditional credit markets, backed by one of Europe’s largest insurers, Legal & General Group PLC, is providing financing to support Eurazeo’s proposed investment in Aroma-Zone, an online retailer making and distributing essential oils and natural beauty and wellness products based in Cabrières-d’Avignon, Provence, in France.
Together with Partners Group and Bank of Ireland, Pemberton has provided a flexible and tailored financing solution to help the company accelerate its growth.
Founded in 1999, Aroma-Zone has grown into the leading company in France around natural and DIY (Do-it-yourself) beauty and wellness, and one of
Novo Holdings has co-led an oversubscribed CHF100 million (approximately USD110 million) Series C financing in Numab Therapeutics AG (Numab) alongside HBM Partners, with participation from new investors Forbion via its Forbion Growth Opportunities Fund, Cormorant Asset Management, BVF Partners, RTW Investments, fund and accounts under the management of BlackRock, Octagon Capital Advisors, and existing investors.
Numab is a clinical stage biopharmaceutical company developing next-generation multispecific antibody-based immunotherapies for cancer and inflammation. Nanna Lüneborg, Partner at Novo Ventures, will join Numab’s Board of Directors.
Based near Zurich in Switzerland, Numab is creating multi-specific antibodies that enable the pursuit of novel
Events
12 November, 2026 – 8:00 am
12 November, 2026 – 5:00 pm
